|Bid||23.00 x 68800|
|Ask||23.20 x 1500|
|Day's range||23.55 - 23.95|
|52-week range||20.19 - 27.73|
|PE ratio (TTM)||28.45|
|Earnings date||28 Feb 2018|
|Forward dividend & yield||0.32 (1.21%)|
|1y target est||25.88|
Grifols shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.
A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Barclays remains bullish on the European telecoms, seeing positive revenue and EBITDA growth in 2018 across the ...
A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Royal Mail: Credit Suisse downgrades to "underperform" expecting worse letter revenue and a costly labour ...
European shares dipped on Friday as another North Korean missile launch softened appetite for riskier banks and miners but still scored their strongest week since July as attractive valuations tempted ...
Chinese investor Creat Group Corp has offered to buy German blood plasma products maker Biotest for about 1.2 billion euros including debt following its purchase last year of British peer Bio Products ...
European shares edged higher on Thursday, underpinned by a rise in oil stocks as investors mulled implications of Britain formally beginning the process of leaving the European Union. The reaction to Britain formally triggering the Brexit process on Wednesday was fairly muted from European shares, with the FTSE 100 index also ending higher as sterling weakened. The FTSE 100 traded 0.1 percent higher on Thursday.